Aytu BioPharma, Inc.

US$1.83As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AYTUHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (66.71%)
Div yield —
ROE (52.55%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.22
PE TTM —
TSR TTM (19.38%)
Mkt cap US$19.89M
ROIC (28.46%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.31
26.12%
(98.05%)
Hold 2|5|8|6|3
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.02
0.02
0.02
0.02
22.87%
21.48%
25.15%
27.89%
Revenue$M
1.445
1.415
1.417
1.412
0.96%
(4.37%)
(2.90%)
(4.56%)
Peers (US$19.89M)
Cap (US$)
PE
26.95M
—
19.78M
2.549x
Capital
TTM
5Y
10Y
Leveragex
1.403
(0.080)
(0.066)
EBIT/Intx
4.673
0.116
0.130
Own earn%
(4.28)
(41.37)
(44.48)
Sh yield%
10.74
28.42
30.15
Owners
Insiders/Inst%
8.07
67.28
Short interest%
3.38
SBC / revenue%
2.05
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
1–9
$1 testx
—
Incr. ROIC%
21